SurModics, Inc.
SRDX
$27.14
$0.381.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.09M | 29.92M | 33.23M | 30.34M | 31.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.09M | 29.92M | 33.23M | 30.34M | 31.96M |
| Cost of Revenue | 16.20M | 16.37M | -19.98M | 18.21M | 17.33M |
| Gross Profit | 11.89M | 13.56M | 53.21M | 12.13M | 14.63M |
| SG&A Expenses | 12.55M | 12.87M | 10.88M | 16.63M | 13.09M |
| Depreciation & Amortization | 853.00K | 863.00K | 885.00K | 870.00K | 876.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.60M | 30.10M | 30.14M | 35.71M | 31.30M |
| Operating Income | -1.51M | -181.00K | 3.09M | -5.37M | 659.00K |
| Income Before Tax | -4.68M | -2.94M | -1.14M | -5.81M | 166.00K |
| Income Tax Expenses | 527.00K | 707.00K | 2.31M | 1.74M | -81.00K |
| Earnings from Continuing Operations | -5.21M | -3.65M | -3.45M | -7.55M | 247.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.21M | -3.65M | -3.45M | -7.55M | 247.00K |
| EBIT | -1.51M | -181.00K | 3.09M | -5.37M | 659.00K |
| EBITDA | 629.00K | 1.90M | 5.23M | -3.24M | 2.76M |
| EPS Basic | -0.36 | -0.26 | -0.24 | -0.53 | 0.02 |
| Normalized Basic EPS | -0.10 | -0.03 | 0.11 | -0.26 | 0.01 |
| EPS Diluted | -0.36 | -0.26 | -0.25 | -0.53 | 0.02 |
| Normalized Diluted EPS | -0.10 | -0.03 | 0.11 | -0.26 | 0.01 |
| Average Basic Shares Outstanding | 14.28M | 14.23M | 14.19M | 14.17M | 14.15M |
| Average Diluted Shares Outstanding | 14.28M | 14.23M | 14.19M | 14.17M | 14.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |